<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-133169</identifier>
<setSpec>0034-947X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Blood disorders in persons with Down&#146;s syndrome</dc:title>
<dc:description xml:lang="en">Persons with Down&#146;s syndrome have clonal blood disease more frequently than the general population. Most of the times, these occur with specific characteristics and sometimes may also be a cause of death. The condition known as transient myeloproliferative syndrome stands out. This condition is associated to mutations in the GATA gene and generally of self-limited character. However, this syndrome evolves to acute leukemia in approximately 20% of these patients. The global incidence of leukemia is much higher than in the general pediatric population. Among these, acute megakaryoblastic leukemia has special characteristics in this population group and generally has a good prognosis, with a treatment that is less intense than in other children without trisomy. Lymphoblastic leukemia, however, may have a worse prognosis than that of children without constitutional chromosomal disorder. A less described aspect is that regarding the benign conditions and the characteristics of the 3 hematopoietic lines frequently found in DS (AU)</dc:description>
<dc:creator>Andrés, M</dc:creator>
<dc:creator>Fernández, B</dc:creator>
<dc:creator>Fernández-Delgado, R</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Las personas con síndrome de Down presentan una mayor frecuencia de enfermedades clonales hematológicas que la población general. La mayor parte de las veces se presentan con características particulares y en ocasiones son causa de muerte. Destaca la entidad conocida como síndrome mieloproliferativo transitorio, asociado a mutaciones en el gen GATA, generalmente de carácter autolimitado, pero que en, aproximadamente, un 20% de pacientes evoluciona a leucemia aguda. La incidencia global de leucemia es muy superior a la de la población infantil general. De entre ellas, la leucemia aguda megacarioblástica presenta características especiales en este grupo poblacional y suele tener buen pronóstico, con un tratamiento menos intenso que en otros niños sin trisomía. Las leucemias de estirpe linfoblástica, sin embargo, pueden tener un pronóstico peor que el de los niños sin alteración cromosómica constitucional. un aspecto menos descrito es el que concierne a la patología benigna, así como a las peculiaridades de las 3 líneas hematopoyéticas encontradas frecuentemente en el SD (AU)</dc:description>
<dc:source>Rev Esp Pediatr;68(6): 421-423, nov.-dic. 2012.</dc:source>
<dc:identifier>ibc-133169</dc:identifier>
<dc:title xml:lang="es">Alteraciones hematológicas en las personas con síndrome de Down</dc:title>
<dc:subject>^d11520^s22012</dc:subject>
<dc:subject>^d52571^s22012</dc:subject>
<dc:subject>^d11812</dc:subject>
<dc:subject>^d14306^s22012</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d52571^s22016</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d6552^s22016</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d6552^s22012</dc:subject>
<dc:subject>^d24408^s22012</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d2918</dc:subject>
<dc:subject>^d4996^s22021</dc:subject>
<dc:subject>^d30934^s22012</dc:subject>
<dc:subject>^d30934^s22062</dc:subject>
<dc:subject>^d52572^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>201212</dc:date>
</metadata>
</record>
</ibecs-document>
